These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24611438)

  • 41. Hypertensive encephalopathy associated with anabolic-androgenic steroids used for bodybuilding.
    Edvardsson B
    Acta Neurol Belg; 2015 Sep; 115(3):457-8. PubMed ID: 25319132
    [No Abstract]   [Full Text] [Related]  

  • 42. [Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].
    García-Esperón C; Hervás-García JV; Jiménez-González M; Pérez de la Ossa-Herrero N; Gomis-Cortina M; Dorado-Bouix L; López-Cancio Martinez E; Castaño-Duque CH; Millán-Torné M; Dávalos A
    Rev Neurol; 2013 Mar; 56(6):327-31. PubMed ID: 23483467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Health Authority Control Measures Aimed at Reducing the Illicit Use of Anabolic-Androgenic Steroids.
    Vázquez-Mourelle R; Carracedo-Martinez E; Figueiras A
    Eur Addict Res; 2018; 24(1):28-36. PubMed ID: 29448243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drugs and violent death: comparative toxicology of homicide and non-substance toxicity suicide victims.
    Darke S; Duflou J; Torok M
    Addiction; 2009 Jun; 104(6):1000-5. PubMed ID: 19466923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-natural manners of death among users of illicit drugs: Substance findings.
    Delaveris GJ; Teige B; Rogde S
    Forensic Sci Int; 2014 May; 238():16-21. PubMed ID: 24637034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anabolic androgenic steroids and aggression: studies using animal models.
    McGinnis MY
    Ann N Y Acad Sci; 2004 Dec; 1036():399-415. PubMed ID: 15817752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships.
    Büttner A; Thieme D
    Handb Exp Pharmacol; 2010; (195):459-84. PubMed ID: 20020376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - results of an international study.
    Geyer H; Parr MK; Mareck U; Reinhart U; Schrader Y; Schänzer W
    Int J Sports Med; 2004 Feb; 25(2):124-9. PubMed ID: 14986195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
    Santos MA; Oliveira CV; Silva AS
    Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anabolic androgenic steroid abuse in the United Kingdom: An update.
    Mullen C; Whalley BJ; Schifano F; Baker JS
    Br J Pharmacol; 2020 May; 177(10):2180-2198. PubMed ID: 31989581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The metabolism of anabolic-androgenic steroids in the greyhound.
    McKinney AR; Cawley AT; Young EB; Kerwick CM; Cunnington K; Stewart RT; Ambrus JI; Willis AC; McLeod MD
    Bioanalysis; 2013 Apr; 5(7):769-81. PubMed ID: 23534422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgenic-anabolic steroids abuse in males.
    Di Luigi L; Romanelli F; Lenzi A
    J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abuse of supraphysiologic doses of anabolic steroids.
    Hall RC; Hall RC
    South Med J; 2005 May; 98(5):550-5. PubMed ID: 15954512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual use of anabolic-androgenic steroids and narcotics in Sweden.
    Gårevik N; Rane A
    Drug Alcohol Depend; 2010 Jun; 109(1-3):144-6. PubMed ID: 20064696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use.
    Hakansson A; Mickelsson K; Wallin C; Berglund M
    Eur Addict Res; 2012; 18(2):83-90. PubMed ID: 22286840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in neuromuscular performance and muscle fiber characteristics of elite power athletes self-administering androgenic and anabolic steroids.
    Alén M; Häkkinen K; Komi PV
    Acta Physiol Scand; 1984 Dec; 122(4):535-44. PubMed ID: 6524396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.